Summary of Purpose
Stroke is a prevalent atherosclerosis vascular disease with high mortality, external counter pulsation (ECP) is an approved noninvasive therapy for angina, congestive heart failure, myocardial infarction, and cardiogenic shock that augments blood flow to cardiac and systemic circuits, which improves the flow volume in the carotid. Though ECP is Ⅱa recommendation for stroke management, no multi-center control...Read More →
The following dates are available for this trial. Trial information last updated on 12 December 2017.
|10 Jun 2018||28 Feb 2017||31 May 2019||30 Jun 2019||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All
- Guifu Wu, PhD
- Jianhang Du, PhD